Pacific Edge shares more than double on US healthcare news

Pacific Edge shares more than double on US healthcare news
Brent Melville
Pacific Edge shares more than doubled in value on confirmation of acceptance under a key US medical regulation for its Cxbladder cancer test. The shares jumped as high as 68 cents from 27 cents yesterday, and were recently at 55 cents, up 104 percent and valuing the company at $379.3 million. The successful standard of care rating from the US Centres for Medicare and Medicaid Services means Pacific Edge will be reimbursed at a rate of US$760 per test from July 1, 2020.  The CMS provides healthcare coverage for all US citizens over the...

More Services

Hundreds of ECE centres backtracking on pay parity
Policy

Hundreds of ECE centres backtracking on pay parity

96% of daycares have opted into pay parity, but govt funding doesn't match the costs.

Demand pricing may be coming to a movie theatre near you
Markets

Demand pricing may be coming to a movie theatre near you

NZX-listed Vista is rolling out a suite of AI innovations.

Govt 'will consult' on NZ Post review, minister says
Services

Govt 'will consult' on NZ Post review, minister says

The deadline for a review of the postal service is up this month.

Maria Slade 14 Jun 2024
Finance group ELF moves into Aussie PE hands
Infrastructure

Finance group ELF moves into Aussie PE hands

Maui Capital Aqua Fund investors are set to double their initial outlay with the sale.

Victoria Young 04 Jun 2024